International safety notice

Urgent Safety Notice for the products Gelweave™, Thoraflex™ Hybrid, BioValsalva™ Stentless Biplex™ Conduits, Stented BioValsalva™ Biplex™ Conduits and RVOT elan™ Biplex™ Conduits, Vascutek Ltd.

Germany / BfArM · DEU · Aug 21, 2014

Key facts

Title Urgent Safety Notice for the products Gelweave™, Thoraflex™ Hybrid, BioValsalva™ Stentless Biplex™ Conduits, Stented BioValsalva™ Biplex™ Conduits and RVOT elan™ Biplex™ Conduits, Vascutek Ltd.
Regulator Germany / BfArM
Country DEU
Brand the products Gelweave™, Thoraflex™ Hybrid, BioValsalva™ Stentless Biplex™ Conduits, Stented BioValsalva™ Biplex™ Conduits and RVOT elan™ Biplex™ Conduits, Vascutek Ltd.
Manufacturer Urgent Safety Notice for the products Gelweave™, Thoraflex™ Hybrid, BioValsalva™ Stentless Biplex™ Conduits, Stented BioValsalva™ Biplex™ Conduits and RVOT elan™ Biplex™ Conduits, Vascutek Ltd.
Date Aug 21, 2014
Regulator page bfarm.de

At a glance

  • No Recall
  • No Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices